Collegeville, PA, United States of America

Kenneth J Holroyd

USPTO Granted Patents = 8 

Average Co-Inventor Count = 4.9

ph-index = 1

Forward Citations = 5(Granted Patents)


Location History:

  • Plymouth Meeting, PA (US) (2003 - 2007)
  • Collegeville, PA (US) (2003 - 2010)

Company Filing History:


Years Active: 2003-2010

Loading Chart...
8 patents (USPTO):Explore Patents

Title: The Innovations of Kenneth J. Holroyd: A Leader in Asthma Therapeutics

Introduction: Kenneth J. Holroyd, an esteemed inventor based in Collegeville, PA, has made significant contributions to the field of biomedicine with a focus on asthma-related research. With a remarkable portfolio comprising 8 patents, Holroyd's innovations have paved the way for novel diagnostic and therapeutic approaches to atopic asthma, improving outcomes for patients worldwide.

Latest Patents: Among his notable inventions are two groundbreaking patents concerning interleukin-9 receptor mutants and nucleic acid encoding the same receptor variants. These inventions delve into the diagnosis and treatment of atopic asthma and related disorders, specifically highlighting the significance of variants of Asthma Associated Factor 2 (AAF2). One embodiment of Holroyd's work involves a key deletion at codon 173, resulting in a non-functional AAF2 protein. This deletion correlates with reduced evidence of atopic asthma, presenting a promising avenue for therapeutic development. The patents also cover isolated DNA molecules and the proteins they encode, offering valuable tools for the diagnosis and treatment of this condition.

Career Highlights: Kenneth J. Holroyd has achieved considerable recognition in the biopharmaceutical industry, primarily through his work at Genaera Corporation. His contributions have transformed the landscape of therapeutic options for asthma, cementing his reputation as a prominent figure in the field.

Collaborations: Holroyd has collaborated with notable peers, including Roy Clifford Levitt and Nicholas C. Nicolaides, enriching his research and fostering innovation in the quest for effective asthma treatments. These collaborations have further enhanced the impact of his work in the scientific community.

Conclusion: Kenneth J. Holroyd's innovative contributions to asthma therapeutics exemplify the power of scientific research in addressing complex health challenges. With a focus on the molecular mechanisms underlying atopic asthma, his patents are poised to lead to significant advancements in diagnosis and treatment, reflecting his commitment to improving patient care through innovative solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…